Navigation Links
Verathon Inc., Recognized, Second Year Running, as Outstanding Workplace in Washington State by Washington CEO Magazine
Date:6/20/2008

mmunication, training, responsibility and decision-making, performance standards, rewards and recognition, benefits, leadership, work environment, hiring and retention and corporate culture. The data were compiled by an independent market research firm, and then a distinguished panel of judges reviewed the data and comments from the employees.

About Verathon Inc.

Verathon(R), formerly Diagnostic Ultrasound Corp., designs and manufactures reliable, state-of-the-art medical devices and services that offer a meaningful improvement in patient care to the health care community. The company's noninvasive BladderScan(R) instrument is the standard of care for bladder volume measurement. The brand is found in over 60 countries in Urology and Primary Care practices, as well as Acute and Extended Care facilities. With the January 2006 acquisition of Saturn Biomedical Systems in Vancouver, Canada, Verathon(R) entered Anesthesiology, Critical Care and Emergency markets with the GlideScope(R) video laryngoscope (GVL(R)) brand. Verathon(R) is headquartered in Bothell, Washington and has approximately 360 employees worldwide. For more information, please visit http://www.verathon.com.

Media Contact: Jane Mueller, VP of Marketing, Verathon Medical Inc., 425.867.1348, Ext. 5600. Alternate Contacts: Nansea Carmichael - Marketing, 425.867.1348, Ext. 5607

Copyright 2008, Verathon Inc. BladderScan(R), GlideScope(R), GVL(R), Verathon(R), and Verathon Medical(R) are either registered trademarks or trademarks of Verathon Inc. in the United States and/or other countries. All rights reserved.


'/>"/>
SOURCE Verathon Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Verathon(R) Offers Enhanced BladderScan(R) Instrument as Part of Continued Program to Eliminate Unnecessary Catheterizations, Decrease Urinary Tract Infections and Assist in Hospital Infection Control
2. Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode
3. Aircraft Medical Files Counter Action Against Verathon
4. Verathon Inc., maker of GlideScope(R) Video Laryngoscopes, Introduces Free Grant Writing Kit for EMS Professionals
5. European Patent Office Upholds Verathons IP Against Aircraft Medical Challenge
6. Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloittes 2007 Washington State Technology Fast 50 for 4th Time in Past 6 Years
7. Verathon Inc. Introduces GlideScope(R) Ranger Single Use Video Laryngoscope for Emergency Departments, EMS and Military; Enables Fast Intubations and Eliminates Time-Consuming Disinfection
8. Mylan Inc., NATCO Pharma Ltd. To Collaborate on Worldwide Marketing and Distribution of Generic Copaxone(R)
9. GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
10. Charterhouse Group Partners with MTS Health Investors and Highlander Partners to Acquire Chamberlin Edmonds & Associates, Inc., a Leading Provider of Eligibility Services to Hospitals
11. Medtronic Spine, Formerly Kyphon Inc., to Pay U.S. $75 Million to Resolve Allegations Of Defrauding Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... A US Airman, fresh from basic training...leukemia patient whose life he saved by donating h...san Air Base, Republic of Korea (PRWEB) November 2...Airman whose blood donation saved her life, met fo...Nov. 21, 2008. , , , , ,Airman Tamarias Pope, 8th...
(Date:11/21/2008)...g of shareholders to be held on January 8, 2009 ,... Med-Emerg International Inc. ("MedEmerg") (OTCBB:...h services, announced today that it has obtained a... Justice concerning its previously announced plan ...ch AIM Health Group Inc. ("AIM") will acquire all ...
(Date:11/21/2008)...., Nov. 21 Heska Corpora...esent at the New York Society of,Security Analyst...ence on,December 2, 2008 at 1177 Avenue of the Am...on is scheduled to begin at 9:35 a.m. Eastern Time...via live webcast and for two weeks,following the ...
(Date:11/21/2008)...Banzel proved effective against Lennox-Gastaut syn...s) -- A new drug called Banzel (rufinamide) has be...ere form of epilepsy called Lennox-Gastaut syndrom... Friday. , The approval was based on results of...s ages 4 to 30. Compared to patients who took a pl...
Breaking Medicine News(10 mins):Health News:Life-Saving Airman, Leukemia Patient Meet for First Time 2Health News:Life-Saving Airman, Leukemia Patient Meet for First Time 3Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:FDA Approves New Drug for Severe Epilepsy 2
...study shows a clear link between fast food consump...sting that // fast food increases the risk of obes...the association between reported fast food habits ...insulin resistance over 15 years. The diets of mor...
...nk between migraines and the risk of coronary hear...t study shows // no link between the two but does ...est pain, also known as angina. People with a hist... aura -- seeing what appears to be spots or lines ...
...t form of macular degeneration represents about 10...lated macular degeneration is the leading cause of...rs of age and older. // Two new studies show a the...n effective treatment for age-related, "wet" macul...
..., more intense physical activity can help maintain...rchers according to // a new study. For the study ...1900 and 1920 from the Finland, Italy, and Netherl...ty of physical activities of the participants was ...
Other Medicine News:
(Date:11/20/2008).... 20 PAREXEL Internation... biopharmaceutical services provider, today announ...provide regulatory consulting and clinical researc...ce, PAREXEL now has locations throughout five impo...which also include Argentina, Brazil, Chile, and M...
(Date:11/19/2008)...ientists report basic findings on critical enzyme,...better treat an array of disorders , , MEMP...ientists at St. Jude Children,s Research Hospital ... the body,s enzyme workhorses called calpains. ,...lpains function in many cellular processes, includ...
(Date:11/18/2008)...christmasseals.org to learn more, make a donation...NGTON, Nov. 17 Millions...th, courtesy of the American Lung Association. The... fundraising tradition dating back to 1907 when th...osis. , , "Most Americans alive today hav...
(Date:11/13/2008)..., Mass., Nov. 13 Hologic...facturer and supplier of premium,diagnostics, medi...d to,serving the healthcare needs of women, today ...k pivotal clinical trial. The Cervista HPV high-ri...e U.S. and is expected to be,launched in the Europ...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4PhoneTree Announces New Patient Messaging Product and Pricing Options 4660 1Roper Industries Announces Record Third Quarter Results 4657 1Roper Industries Announces Record Third Quarter Results 4657 2Roper Industries Announces Record Third Quarter Results 4657 3Roper Industries Announces Record Third Quarter Results 4657 4Roper Industries Announces Record Third Quarter Results 4657 5Roper Industries Announces Record Third Quarter Results 4657 6Roper Industries Announces Record Third Quarter Results 4657 7Roper Industries Announces Record Third Quarter Results 4657 8Roper Industries Announces Record Third Quarter Results 4657 9Roper Industries Announces Record Third Quarter Results 4657 10Male Drivers are Hitting Killing Most Child Pedestrians New Study Shows 4654 1Male Drivers are Hitting Killing Most Child Pedestrians New Study Shows 4654 2Male Drivers are Hitting Killing Most Child Pedestrians New Study Shows 4654 3California Association of Marriage 26 Family Therapists Offers Tips on How to Cope With a Traumatic Event 4651 1California Association of Marriage 26 Family Therapists Offers Tips on How to Cope With a Traumatic Event 4651 2
... at International Conference on Antiviral,Research...- ADVENTRX,Pharmaceuticals, Inc. , a biopharmaceut...ommercializing proprietary product,candidates for ...nnounced today that it presented results demonstra...influenza (bird flu) viruses when,the Company,s br...
...Plus Minocycline Showed Substantial,Reduction of D...Remitting Multiple Sclerosis , Combination Treatme...nd Was Well Tolerated , KANSAS CITY, Mo, May 4, 20...y showed that a combination of Copaxone,(glatirame...c,minocycline reduced T1 Gadolinium (Gd)-enhancing...
Other Medicine Technology:ANX-201 Drug Combination Demonstrates Synergistic Activity Against,Human and Bird Flu Viruses 2ANX-201 Drug Combination Demonstrates Synergistic Activity Against,Human and Bird Flu Viruses 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 6Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 7Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 8Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 9Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 10Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 11Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 12
Needle holder, delicate, curved without lock
Rhoton microscopic forceps, straight
Microscopic scissors, curved
Our unique velcro design apron with elasticized back panels for additional support and comfort. Shoulder pads are a standard. Shoulder drop-away optional.
Medicine Products: